Pfizer COVID-19 vaccine safety monitoring and surveillance in Ethiopia

Ethiopian Food and Drug Authority

dc.contributor.author	Ethiopian Food and Drug Authority
dc.date.accessioned	2024-01-01T05:56:44Z
dc.date.available	2024-01-01T05:56:44Z
dc.date.issued	2022
dc.identifier.uri	http://repository.iphce.org/xmlui/handle/123456789/2680
dc.description.abstract	Adverse Events Following Immunizations (AEFIs) are reported to Ethiopian Food and Drug Authority (EFDA) by health care providers and vaccine recipients. EFDA investigates and assesses all AEFI reports and conducts causality analysis where necessary and take appropriate actions accordingly	en_US
dc.language.iso	English	en_US
dc.subject	Infectious diseases/COVID-19	en_US
dc.title	Pfizer COVID-19 vaccine safety monitoring and surveillance in Ethiopia	en_US
dc.title.alternative	Adverse Events Following Immunizations (AEFIs) Reports of Pfizer-BioNTech Covid-19 Vaccine in Ethiopia for two round	en_US
dc.type	Report	en_US